Coronavirus Boosts Biogen Biosimilars In First Quarter

As Company Comments On Recent US Tecfidera Ruling

 
• By Dean Rudge
DigitalMap
Biogen's biosimilar sales in Europe are tracking north of $800m this year • Source: Shutterstock

More from Earnings

More from Business